Patient Assistance Program Application - jjpaf.org
* See full U.S. prescribing information, including Black Box warning. † Contact Amgen Inc. 1-800-772-6436. Revised: July 2018 Patient …
Download Patient Assistance Program Application - jjpaf.org
Information
Domain:
Source:
Link to this page:
Documents from same domain
Patient Assistance Program Application - JJPAF
jjpaf.orgPatient Assistance Program Application. INSTRUCTIONS FOR ENROLLMENT. Ask your Healthcare Professional (HCP) to complete, and . sign and date. page 3. Submit completed pages . 2 and 3 only. with documentation to: Mail: Johnson & Johnson Patient Assistance Foundation, Inc. Patient Assistance Program. PO Box 0367, Chesterfield, MO 63006. Fax:
Related documents
Association Bulletin #16-02 AABB Members Donna …
www.aabb.orgtreated cells is performed; such antibodies are encountered infrequently, however. Crossmatch For patients with a negative antibody screen using DTT …
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
www.ema.europa.eu2 This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions.
Understanding DARZALEX Interference With Blood ...
www.darzalexhcp.comDARZALEX® (daratumumab) Results in a False Positive Indirect Coombs Test • DARZALEX® is a human monoclonal antibody for the treatment of multiple myeloma1 • ®DARZALEX binds to CD38,2 a protein that is expressed